Chemico-genetic strategies to inhibit the leukemic potential of threonine aspartase-1

Blood Cancer Journal

Volumn 2, Issue 6, 2012, Pages

  Wunsch D ^a   Fetz, V ^a   Heider, D ^b   Tenzer, S ^a   Bier, C ^a   Kunst, L ^a   Knauer, S ^b   Stauber, R ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTATE AMMONIA LYASE; CD34 ANTIGEN; GLUTATHIONE TRANSFERASE ALPHA; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEINASE; THREONINE ASPARTASE 1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; BIOSENSOR; CANCER GENETICS; CANCER INHIBITION; CELL LINEAGE; CHROMOSOME REARRANGEMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; HUMAN; LETTER; LEUKEMIA; MOLECULAR DOCKING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; WILD TYPE;

EID: 84864037704     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.22     Document Type: Letter

References (9)

1. Bursen A, Schwabe K, Ruster B, Henschler R, Ruthardt M, Dingermann T et al. The AF4bulletMLL fusion protein is capable of inducing ALL in mice without requirement of MLLbulletAF4. Blood 2010; 115: 3570-3579.
2. Montes R, Ayllon V, Gutierrez-Aranda I, Prat I, Hernandez-Lamas MC, Ponce L et al. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. Blood 2011; 117: 4746-4758.
3. Hsieh JJ, Cheng EH, Korsmeyer SJ. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell 2003; 115: 293-303. (Pubitemid 37487703)
4. Knauer SK, Fetz V, Rabenstein J, Friedl S, Hofmann B, Sabiani S et al. Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors. Plos One 2011; 6: e18253, 1-14.
5. Pless B, Oehm C, Knauer S, Stauber RH, Dingermann T, Marschalek R. The heterodimerization domains of MLL-FYRN and FYRC-are potential target structures in t(4;11) leukemia. Leukemia 2011; 25: 663-670.
6. Chen DY, Liu H, Takeda S, Tu HC, Sasagawa S, Van Tine BA et al. Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis. Cancer Res 2011; 70: 5358-5367.
7. Khan JA, Dunn BM, Tong L. Crystal structure of human Taspase1, a crucial protease regulating the function of MLL. Structure 2005; 13: 1443-1452. (Pubitemid 41427584)
8. Chen DY, Lee Y, Van Tine BA, Searleman AC, Westergard TD, Liu H et al. A Pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth. Cancer Res 2011; 72: 736-746.
9. Saunders LP, Ouellette A, Bandle R, Chang WC, Zhou H, Misra RN et al. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Mol Cancer Ther 2008; 7: 3352-3362.